Exagen (XGN) Net Cash Flow (2018 - 2026)

Exagen (XGN) has 9 years of Net Cash Flow data on file, last reported at -$10.7 million in Q1 2026.

• Quarterly Net Cash Flow rose 1.25% year-over-year to -$10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (up 164.2% YoY) and the FY2025 annual result came in at $10.2 million, up 170.44% from the prior year.
• Net Cash Flow eased to -$10.7 million in Q1 2026, from -$3.4 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $18.8 million in Q2 2025 to a low of -$20.7 million in Q2 2023.
• A 5-year average of -$4.6 million and a median of -$6.3 million in 2022 frame the typical range for Net Cash Flow.
• The widest YoY moves for Net Cash Flow: up 775.72% in 2025, down 343300.0% in 2025.
• Tracing XGN's Net Cash Flow over 5 years: stood at -$6.3 million in 2022, then jumped by 227.44% to $8.0 million in 2023, then plunged by 99.99% to $1000.0 in 2024, then slumped by 343300.0% to -$3.4 million in 2025, then tumbled by 211.98% to -$10.7 million in 2026.
• The last three Net Cash Flow figures came in at -$10.7 million (Q1 2026), -$3.4 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.